Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11286300 Humanized anti-human CD19 antibodies and methods of use
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
September 30, 2016
0
Date of Patent
March 29, 2022
0
Patent Application Number
15763868
0
Patent Citations Received
US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules
0
US Patent 11639394 Bispecific antigen binding molecule for a costimulatory TNF receptor
0
US Patent 11780920 Antibodies binding to CD3 and CD19
US Patent 11993642 Trivalent, bispecific antibodies
0
US Patent 11999801 Multispecific antibodies
0
Patent Inventor Names
Tilman Schlothauer
0
Alexander Haas
0
Claudia Ferrara Koller
0
Ekkehard Moessner
0
Guy Georges
0
Hubert Kettenberger
0
Laurent Lariviere
0
Michael Molhoj
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11286300
0
Patent Primary Examiner
Chun W Dahle
0
Find more entities like US Patent 11286300 Humanized anti-human CD19 antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE